SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
344.20    8.00 (2.38%)
Bid:
344.00
Ask:
344.40
Spread: 0.40 (0.116%)
Market Cap: £2.51b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Interim Management Statement

10 May 2012 07:00

RNS Number : 0294D
Tullett Prebon PLC
10 May 2012
Β 

10 May 2012

Β 

Tullett Prebon plc

Β 

AGM Statement and Interim Management Statement

Β 

Tullett Prebon plc (the "Company") is today issuing its Interim Management Statement in relation to the period from 1 January 2012. This statement will be delivered to those attending the Annual General Meeting today.

Β 

Business Update

Β 

Market conditions have continued to be challenging. The overall level of market activity in all three regions in the first part of the year has been slightly lower than in the same period last year.

Β 

Revenue in the four months to April was Β£305m, in line with that reported for the equivalent period last year. At constant exchange rates, and excluding the recent acquisitions of ConvenΓ§Γ£o and Chapdelaine, revenue was 4% lower.

Β 

In the light of the challenging market and competitive conditions and the increased costs faced by the business relating to electronic platform development and other costs related to impending regulatory changes, a number of actions were taken towards the end of 2011 to reduce costs and to maintain flexibility in the cost base. Further actions have been taken in 2012, as discussed in the 2011 preliminary results announcement. These further actions now involve a reduction in headcount of 140, split broadly two-thirds front office, one-third support, with a cost to achieve of Β£14m, and an annual reduction in fixed costs of approximately the same amount. The cost of these actions will be included as an exceptional charge in the 2012 accounts.

Β 

On 22 March the Company announced that it had submitted a motion to the New York Court to confirm the arbitral award made by a tribunal of the American Arbitration Association in connection with claims by BGC that the Company's information sales subsidiary misused certain market data it was being supplied under a redistribution agreement. The arbitrator's award is that the Company should pay BGC $0.8m plus interest at the statutory rate from 1 January 2010. BGC's application for reasonable attorney's fees and costs was denied. In response to the Company's motion, BGC have cross moved seeking to vacate the arbitrator's award. The outcome of these motions is expected to be known later this year.

Β 

Legal action continues to be pursued against BGC and former employees in the United States. The FINRA arbitration on the claim brought by the subsidiary companies in the United States directly affected by the raid on the business by BGC in the second half of 2009 has commenced and is expected to continue through the remainder of the year. A separate action has also been brought by the Company in the New Jersey Superior Court, alleging, among other causes of action, violations under the NJ RICO Act. Since 1 January, Β£3.5m of costs have been incurred in relation to these actions. Consistent with the treatment adopted in 2011, these costs will be recognised as an exceptional charge in the 2012 accounts.

Β 

On 2 May, the Company announced that it had reached agreement to acquire Elevation LLC, an equities and equity derivatives interdealer broker based in New York, for a consideration of $13.0m to be settled in cash on completion. The acquisition is expected to complete before the end of the first half of the year.

Β 

The Company's financial position remains strong.

Β 

Β 

Enquiries:

Β 

Nigel Szembel, Head of Communications, Tullett Prebon plc

Direct: +44 (0)20 7200 7722

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSBIGDUXBGBGDC
Date   Source Headline
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20254:45 pmRNSHolding(s) in Company
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20254:30 pmRNSHolding(s) in Company
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20257:05 amRNSLaunch of fourth share buyback programme of £30m
11th Mar 20257:00 amRNSFinal Results
6th Mar 20254:35 pmRNSHolding(s) in Company
13th Feb 20258:00 amRNSHolding(s) in Company
10th Feb 20254:30 pmRNSHolding(s) in Company
23rd Jan 20255:30 pmRNSDirectorate Change
17th Jan 20252:45 pmRNSHolding(s) in Company
17th Jan 20257:00 amRNSTransaction in Own Shares
16th Jan 20257:00 amRNSTransaction in Own Shares
15th Jan 20257:00 amRNSTransaction in Own Shares
14th Jan 20257:00 amRNSTransaction in Own Shares
13th Jan 20257:00 amRNSTransaction in Own Shares
10th Jan 20257:00 amRNSTransaction in Own Shares
9th Jan 20257:00 amRNSTransaction in Own Shares
8th Jan 20257:00 amRNSTransaction in Own Shares
7th Jan 20257:00 amRNSTransaction in Own Shares
6th Jan 20257:00 amRNSTransaction in Own Shares
3rd Jan 20257:00 amRNSTransaction in Own Shares
2nd Jan 20257:00 amRNSTransaction in Own Shares
31st Dec 20247:00 amRNSTransaction in Own Shares
30th Dec 20247:00 amRNSTransaction in Own Shares
27th Dec 20247:00 amRNSTransaction in Own Shares
24th Dec 20247:00 amRNSTransaction in Own Shares
23rd Dec 20247:00 amRNSTransaction in Own Shares
20th Dec 202410:21 amRNSHolding(s) in Company
20th Dec 20247:00 amRNSTransaction in Own Shares
14th Nov 20247:00 amRNSTransaction in Own Shares
13th Nov 20244:15 pmRNSHolding(s) in Company
13th Nov 20243:00 pmRNSDirector/PDMR Shareholding
13th Nov 20247:00 amRNSTransaction in Own Shares
12th Nov 20247:00 amRNSTransaction in Own Shares
11th Nov 20247:00 amRNSTransaction in Own Shares
6th Nov 20247:00 amRNSTransaction in Own Shares
5th Nov 20247:05 amRNSTransaction in Own Shares
5th Nov 20247:00 amRNSTrading Statement
4th Nov 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.